KRT19 and breast cancer: Cytokeratin-19 (CK-19), a cytoskeletal component present in normal and cancerous epithelial cells, has been extensively used for the detection of breast cancer cells in mesenchymal tissues and seems to be the most sensitive and reliable tumor marker in both patients with operable and metastatic breast cancer [13,14].